Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Giuliani

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Cancers|October 26, 2024
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter StudyPalma Fedele, Matteo Landriscina, Lucia Moraca, et al.
Journal of Clinical Medicine|December 30, 2025
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Alessandro Rizzo, Matteo Landriscina, et al.
Cancers|November 13, 2025
Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Stefania Luigia Stucci, Matteo Landriscina, et al.
Chronobiology International|March 24, 2015
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvationFrancesca Tavano, Valerio Pazienza, Andrea Fontana, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
MARIO Project: Validation and Evidence of Service Robots for Older People with DementiaGrazia D'Onofrio, Daniele Sancarlo, Massimiliano Raciti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 studyGiuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 21, 2023
Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastomaFabiana Gregucci, Fiorella Cristina Di Guglielmo, Alessia Surgo, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Cancers|October 26, 2024
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter StudyPalma Fedele, Matteo Landriscina, Lucia Moraca, et al.
Journal of Clinical Medicine|December 30, 2025
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Alessandro Rizzo, Matteo Landriscina, et al.
Cancers|November 13, 2025
Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisPalma Fedele, Stefania Luigia Stucci, Matteo Landriscina, et al.
Chronobiology International|March 24, 2015
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvationFrancesca Tavano, Valerio Pazienza, Andrea Fontana, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
MARIO Project: Validation and Evidence of Service Robots for Older People with DementiaGrazia D'Onofrio, Daniele Sancarlo, Massimiliano Raciti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 studyGiuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 21, 2023
Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastomaFabiana Gregucci, Fiorella Cristina Di Guglielmo, Alessia Surgo, et al.
Pageof 12